Industry, Business & Agriculture Sessions
Monday, September 9
10:00- 10:30
Hall E
WELCOME WORDS
Uri Ariel, Minister of Agriculture and Rural Development, Israel
Yossi Bornstein, Founder and Partner, Shizim Group and Cann10, Israel
10:30- 11:00
Hall E
Keynote Lecture: THE CANNABINOID SYSTEM: WHERE DO WE STAND TODAY?
Raphael Mechoulam, Institute for Drug Research, The Hebrew University of Jerusalem, Israel
11:30- 12:15
Hall E
CANNABIS AND THE OPIOD EPIDEMIC
Chair: Elyad Davidson, Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel
IS CANNABIS A CURE FOR THE OPIOID EPIDEMIC?
David Casarett, Prof. Chief of Palliative Care, Duke University, USA
THE EXIT DRUG: MEDICAL CANNABIS PATTERNS OF USE AND SUBSTITUTION FOR OPIOIDS AND OTHER SUBSTANCES
Philippe Lucas, VP of Patient Research and Access, Tilray, Canada
12:20- 13:30
Halls F-G-H
THE ISRAEL MODEL: A SMALL COUNTRY, A LEADING INDUSTRY
Chair: Kobi Caspi, Co-founder and CFO, Cann10, Israel
INTRODUCTION
Karina Rubinstein, Director of Business Development, Start Up Division at Israel Innovation Authority, Israel
WHY ISRAEL IS THE RIGHT PLACE TO INVEST IN MEDICAL CANNABIS AND HOW THE ISRAELI GOVERNMENT PROMOTES THE INDUSTRY
Ziva Eger, Chief Executive of Foreign Investments & Industrial Cooperation, Ministry of Economy and Industry, Israel
THE GLOBALIZATION OF MEDICALIZATION
Amir Goldstein, Cheif Operations Officer, IMC, Israel
MILLENIAL PHARMACY – ONLINE CARE
Tal Ben David, Head Pharmacist, GreenPharma, Israel
Liron Goldshtein, Head, Cannabis Pharmacy Dept., GreenPharma, Israel
Q&A
12:20-13:30
Halls K-L-M
CANNABIS GENETICS – NEW DEVELOPMENTS
Chair: Shay Avraham Sarid, Co-Founder & CTO, Seach Medical Cannabis Group, Israel
SECRETS OF THE CANNABIS GENOME
Jonathan Page, Chief Science Officer, Aurora Cannabis Inc., Canada
GLOBAL ACCESS TO INDICATION SPECIFIC GENETICS
Shay Avraham Sarid, Co-Founder and CTO, Seach Medical Cannbis Group, Israel
PRECISE GENOMICS FOR MEDICAL CANNABIS
Arnon Heyman, CEO, Canonic Ltd., Israel
Q&A
14:30-16:05
Halls F-G-H
DIGITAL HEALTH AND CANNABIS – IS THE FUTURE HERE? BIG DATA, PREDICTION, AND ARTIFICIAL INTELLIGENCE
Chair: Gali Weinreb, Editor and Biomed correspondent, Globes, Israel
INTRODUCTION
Gali Weinreb, Editor and Biomed correspondent, Globes, Israel
CANNFORMATICS: A BIOINFORMATICS AND BIG DATA APPROACH TO PERSONALIZED MEDICAL CANNABIS
Itzhak Kurek, CEO and Co-Founder, Cannformatics Inc., USA
CANNABIS BIG DATA – TRACKING PATIENT OUTCOMES FOR PREDICTIVE ANALYTICS
David Berg, President and CTO, Strainprint Technologies Ltd., Canada
TRENDS IN THE MEDICALIZATION OF CANNABIS
Avihu Tamir, CEO, Kanabo Research, Israel
Q&A
GREEN IN RED: MEASURING CANNABINOIDS IN BIOFLUIDS AND TISSUES
Alla Falkovich, Bioanalytical R&D manager and Study Director, Analyst Labs, Israel
14:30 – 16:00
Halls K-L-M
DRUG DELIVERY
Chair: Hadile Ounallah-Saad, VP R&D, Cannassure, Israel
THE FUTURE OF INHALED CANNABINOID-BASED MEDICINE IN CANCER: AN ALTERNATIVE TREATMENT TO IMPROVE QUALITY OF LIFE AND PAIN MANAGEMENT IN ADVANCED CANCER PATIENTS
Martin Chasen, Vice President Clinical Programs Medical Affairs, Tetra Bio-Pharma, Canada
CHALLENGES IN MEDICALIZATION OF CANNABIS
Hadile Ounallah-Saad, VP R&D, Cannassure, Israel
TRANSDERMAL DELIVERY OF CANNABINOIDS: HUMAN CASE STUDIES
Jeremy Riggle, Chief Scientist, Mary’s Medicinals, USA
Q&A
Tuesday, September 10
09:00 – 10:00
3 Parallel Halls
Click HERE to view the Oral Presentation page
10:00 – 11:30
Halls F-G-H
ENTERING THE PHARMACEUTICAL INDUSTRY – HOW TO MEET PHARMA STANDARDS IN CANNABIS BASED PRODUCTS
Chair: Orna Dreazen, CEO and Chairperson of the Board of Directors, Nextar Chempharma Solutions Ltd., Israel
KEYNOTE LECTURE: THE ISRAELI ROAD MAP TO MEDICAL GRADE CANNABIS – A BRIDGE OVER TROUBLED WATER
Arnon Afek, Associate Director General, Sheba Medical Center, Acting Chief Physician, Israeli Medical Cannabis Agency, Ministry of Health, Israel
SYQE INHALER SETTING THE STAGE FOR A NEW STANDARD OF CARE
Ianiv Eisenscher, Chief Product Officer, Syqe Medical, Israel
HOW TO MEET PHARMA STANDARDS IN CANNABIS BASED PRODUCTS?
Orna Dreazen, CEO and Chairperson of the Board of Directors, Nextar Chempharma Solutions Ltd., Israel
Q&A
10:00- 11:30
Halls K-L-M
10:00 – 10:40
THC VS. CBD – TRIANGLE RELATIONSHIP: REGULATION, RESEARCH & INDUSTRY
INTRODUCTION
Narkis Tessler, CEO, TeraCann, Israel
DISEASE SPECIFIC CBD USE IN CHRONIC AILMENTS
Miles Gilman, President, Sunhealth Therapeutic, USA
THC AS A THERAPEUTIC AGENT
Dror Robinson, Chairman of the Israeli Association of Cannabis Medicine, Israel
10:40 – 11:30
DEBATE: WILL THE HEMP INDUSTRY TAKEOVER?
Moderator: Narkis Tessler, CEO, TeraCann, Israel
Clifton Flack, Founder, Ciitech, Israel
Maayan Weisberg Joels, Business Development Manager, Tikun Olam, Israel
12:00 – 13:00
Halls K-L-M
DECISION-MAKERS PANEL – THE POLITICAL ANGLE OF THE MEDICAL CANNABIS FIELD
Moderator: Daphna Liel, Correspondent, Channel 12
Panelists: Prominent Israeli Political Figures
14:00 -15:30
Halls F-G-H
GLOBAL TRADE: OVERCOMING IMPORT-EXPORT BARRIERS IN A CONSTANTLY CHANGING REGULATORY ENVIRONMENT
Moderator: Lior Kenan, Economics Correspondant, Chanel 13, Israel
THE ROADMAP FROM MEDICALISATION TO EXPORT
Itai Melchior, Senior Project Manager at Foreign Trade Administration – Ministry of Economy and Industry, Israel
BREAKTHROUGH IN BRAZIL & LATIN AMERICA: CANNABIS INDUSTRY REGULATIONS, CHALLENGES AND OPPORTUNITIES
Elizabeth Hatchuel, Adjunct Professor, Universidade Federal Rural do Rio de Janeiro, Brazil
PANEL DISCUSSION
Philippe Lucas,VP, Global Patient Research & Access, Tilray Social Dimensions of Health, University of Victoria Graduate Researcher, Canadian Institute for Substance Use Research, Canada
Hagit Weinstock, Owner and Partner, Weinstock Zehavi & Co. Law Firm, Israel
Boaz Wachtel, Co-Founder and Chairman, Creso Pharma, Australia
Saul Kaye, Founder and CEO, ICAN Israel Cannabis, Israel
Dadi Segal, CEO, Panaxia, Israel
Yossi Bornstein, Founder and Partner, Shizim Group and Cann10. Israel
14:45 – 15:30
Halls K-L-M
HIGH-END TECHNOLOGIES FOR BEST CULTIVATION AND PLANT PROTECTION
Chair: Gilad Livni, Cannabis Consulted Breeder, Israel
THE FUTURE OF CANNABIS CULTIVATION: AUTOMATED GROWING TECHNOLOGIES
Zohar Levy, CEO, Seedo Lab, Israel
AUTOMATED HIGH QUALITY CONTROLLED–THE SAFE WAY TO PROTECT YOUR HARVEST
Ofer Finkelstein, VP Sales, Juganu, Israel
ISRAEL LATEST ADVANCES IN CANNABIS CULTIVATION TECHNOLOGIES
Gilad Livni, Cannabis Consulted Breeder, Israel
15:30 -15:50
Hall E
FIRESIDE CHAT
Moderator: Ariel Sender, Chief Business Director, Gilad Group, Israel
Ehud Barak, Chairman of Canndoc & Former Prime Minister, Israel
16:15 -16:35
Hall E
KEYNOTE DUO:
THE CANNABIS MARKET – NEW GROWTH OPPORTUNITIES
Rishi Malkani, Cannabis Practice Leader, Partner, M&A Advisory, Transaction Services, Deloitte Canada
Nadav Gil, Partner, Cannabis Tech Leader Global Investment and Innovation Incentives, Deloitte Israel
16:35 -17:25
Hall E
THE MEDICAL CANNABIS CAPITAL MARKET – AN ECONOMIC BUBBLE OR THE REAL THING?
Moderator: Sophie Shulman, Capital Markets Editor, Calcalist, Israel
PANEL DISCUSSION:
Panelist: Steve Hawkins, President and CEO, Horizons ETFs, Canada
Panelist: Shiry Eden, Founder and CEO, Nishot, Israel
Panelist: Brenda Smith, MBA, CFP®, Founder, Managing Partner, CB Capital Concierge, Chair, Tiger 21, Board, America-Israel Cannabis Association, USA
Panelist: Ilan Gerzi, Senior Partner, Chair of the Capital Markets and Securities Group at Pearl Cohen, Israel
Panelist: Rishi Malkani, Cannabis Practice Leader, Partner, M&A Advisory, Transaction Services, Deloitte Canada
17:25 -17:30
Hall E
CLOSING ADDRESS
Yossi Bornstein, Founder and Partner, Shizim Group and Cann10, Israel